Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

21.58
Delayed Data
As of Sep 28
 -0.52 / -2.35%
Today’s Change
19.10
Today|||52-Week Range
46.24
-50.00%
Year-to-Date

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Myriad Genetics Inc have a median target of 21.50, with a high estimate of 42.00 and a low estimate of 18.00. The median estimate represents a -0.37% decrease from the last price of 21.58.

Analyst Recommendations

The current consensus among 17 polled investment analysts is to Hold stock in Myriad Genetics Inc. This rating has held steady since September, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.26
Sales
$169.5M
Reporting Date
Nov 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -28.38%
 
 
 
 
 
 
Growthannually -35.68%
 
 
 
 
 
 

Sales

Growthquarterly -9.11%
 
 
 
 
 
 
Growthannually -0.73%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.